Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MitoQ for Physiological Function in Older Adults
NCT02597023Completed
- Sponsor
- University of Colorado Boulder
- Start
- Sep 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of mitoquinone in aging, sponsored by University of Colorado Boulder. Primary endpoint: Endothelium-dependent dilation at 6 weeks. Started Sep 2015; status: completed.
02
Drugs
mitoquinone
03
Conditions
aging
Beyond the preview
Go deeper on NCT02597023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02597023.